Jean Duvall
Directeur/Membre du Conseil chez ONDINE BIOMEDICAL INC.
Fortune : 13 994 $ au 30/04/2024
Postes actifs de Jean Duvall
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONDINE BIOMEDICAL INC. | Directeur/Membre du Conseil | 07/12/2021 | - |
Independent Dir/Board Member | 07/12/2021 | - | |
ROQUEFORT THERAPEUTICS PLC | Directeur/Membre du Conseil | 05/04/2022 | - |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Directeur/Membre du Conseil | - | - |
Conseiller Juridique Général | 01/11/2006 | - | |
Secrétaire Général | 01/11/2006 | - | |
Repronovo SA | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - |
Historique de carrière de Jean Duvall
Anciens postes connus de Jean Duvall
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ferring Research Ltd. | Directeur/Membre du Conseil | - | - |
International School of Lausanne | Directeur/Membre du Conseil | - | - |
Ferring Properties SA | Directeur/Membre du Conseil | - | - |
Gliotherapy Ltd. | Directeur/Membre du Conseil | - | - |
Kuopio Center For Gene & Cell Therapy Kct oy | Directeur/Membre du Conseil | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Formation de Jean Duvall
Case Western Reserve University | Undergraduate Degree |
The Ohio State University | Graduate Degree |
Statistiques
Internationale
Suisse | 7 |
Royaume-Uni | 7 |
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 18 |
Founder | 3 |
General Counsel | 2 |
Sectorielle
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ONDINE BIOMEDICAL INC. | Health Technology |
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Entreprise privées | 18 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
CPSI Holdings Ltd. | |
Ferring Research Ltd. | |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company is based in Middlesex, UK and was founded in 1980. | Health Technology |
Ferring Pharmaceuticals SA
Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Health Technology |
CPSI Scotland Ltd.
CPSI Scotland Ltd. Financial ConglomeratesFinance Part of CPSI Holdings Ltd., CPSI Scotland Ltd. is a financial services provider. The company is based in East Kilbride, UK. CPSI Scotland was founded in 2011. | Finance |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
FinVector Oy
FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
Kuopio Center For Gene & Cell Therapy Kct oy | |
Trizell Holding SA | |
Repronovo SA | |
Amzell BV | |
Gliotherapy Ltd. | |
International School of Lausanne | |
Ferring Properties SA |
- Bourse
- Insiders
- Jean Duvall
- Expérience